Dianthus Therapeutics, Inc. (DNTH)
87.48
+1.28
(+1.48%)
USD |
NASDAQ |
Apr 08, 16:00
87.56
+0.08
(+0.09%)
After-Hours: 20:00
Dianthus Therapeutics EPS Diluted (Quarterly) : -1.433 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Daré Bioscience, Inc. | -0.0994 |
| Relmada Therapeutics, Inc. | -0.2911 |
| Viridian Therapeutics, Inc. | -1.080 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.43M |
| Revenue (Quarterly) | 0.284M |
| Total Expenses (Quarterly) | 64.72M |
| Enterprise Value | 4.228B |
| Gross Profit Margin (Quarterly) | 65.85% |
| Profit Margin (Quarterly) | -22.69K% |
| Earnings Yield | -4.63% |
| Normalized Earnings Yield | -4.629 |